11.08.21
Gryphon Investors, a leading middle-market private equity firm, today announced it has inked an agreement to acquire Revision Skincare and Goodier Cosmetics (now Revision Goodier).
In partnership with Revision Goodier's leadership team, including CEO Maria Carell, Gryphon will continue to invest in the company's mission of developing and delivering clinically-proven and highly-efficacious skincare products to a global customer base and advance the company's contract development and manufacturing capabilities.
Financial terms of the transaction were not disclosed.
"Revision has a unique position as a high-growth independent company in a compelling market,” said Mike Ferry, Gryphon operating partner. “Skincare consumers are becoming more discerning about the products they use, and we are excited to invest in Revision's mission to help bring carefully formulated and highly efficacious skincare products to a global customer base."
For more than two decades, Revision Skincare has provided dermatologists, plastic surgeons and medical spas with clinically proven, high-performing skincare products. Using only premium quality ingredients, the Revision Skincare collection was formulated to provide targeted solutions for enhancing skin's appearance and reducing signs of aging. Based in Irving, Texas, Revision Skincare is sold in more than 10 countries.
Since 1922, Irving, TX-based Goodier Cosmetics has been a trusted developer and manufacturer in cosmetic and over the counter topical skincare solutions. Differentiated by an industry-renowned Innovation Center of Excellence, Goodier, along with its team of research and development chemists, engineers and regulatory experts, remains at the forefront of market trends, new technologies, ingredients and advancements in formulation science.
"Revision Goodier represents a bullseye opportunity for Gryphon and leverages our proactive focus of investing behind leading efficacious skincare brands,” said Matt Farron, partner and head of Gryphon's Consumer Group. “We are proud to be supporting the team through their next phase of growth."
Revision Goodier's management team will continue to be led by CEO Maria Carell. As part of the transaction, a number of Gryphon executive advisors will join Ferry, Farron, and Gryphon Principal Eddie Douglas on the Board of Directors. The transaction marks Gryphon's third investment in skincare products and services and the first investment in the physician dispensed skincare category.
The transaction is expected to close in the fourth quarter of 2021.